Revised SPCs: Tivicay (dolutegravir) Film-Coated Tablets- all strengths

SPCs have been updated to warn that an increase in weight and in levels of blood lipids and glucose may occur during antiretroviral therapy. Such changes may in part be linked to disease control and lifestyle. For lipids, there is in some cases evidence for a treatment effect.


electronic Medicines compendium